Health

Casgevy: UK approves gene-editing drug for sickle cell



Medical regulators approve a gene therapy that aims to cure sickle cell disease and beta thalassemia.



READ SOURCE

Readers Also Like:  Protesters rally in ’emergency response’ to NHS ‘crisis’

This website uses cookies. By continuing to use this site, you accept our use of cookies.